Search

Your search keyword '"Seder, Robert"' showing total 784 results

Search Constraints

Start Over You searched for: Author "Seder, Robert" Remove constraint Author: "Seder, Robert"
784 results on '"Seder, Robert"'

Search Results

2. Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

4. Author Correction: Intravenous Bacille Calmette–Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis

5. Intravenous Bacille Calmette–Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis

6. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5

7. Defining the risk of SARS-CoV-2 variants on immune protection

11. Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans

12. Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection

15. Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial

16. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine

17. Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria

18. Markov Field network integration of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaques

19. Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel

20. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

21. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine

22. Robust IgM responses following intravenous vaccination with Bacille Calmette–Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques

23. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

24. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults

25. Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates

28. Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial

29. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

30. Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells

32. Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates

33. Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates

34. Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates

36. Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus Macaques

37. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5

38. Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens

39. Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates

40. Antibody-mediated depletion of select leukocyte subsets in blood and tissue of nonhuman primates.

41. Humoral correlates of protection againstMycobacterium tuberculosisfollowing intravenous Bacille Calmette-Guérin vaccination in rhesus macaques

42. Protective intravenous BCG vaccination induces enhanced immune signaling in the airways

43. Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques

44. Bystander responses impact accurate detection of murine and human antigen-specific [CD8.sup.+] T cells

47. Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques

50. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

Catalog

Books, media, physical & digital resources